Roche Registration Gmbh
SpainAll drugs from this manufacturer
-
It is used to treat solid tumors (cancer) in adults, adolescents, and children older than 1 month of age who have a genetic alteration in the NTRK gene. It is also used in adults with a type of non-small cell lung cancer that has a genetic alteration in the ROS1 gene.
Dosage form: capsules, hard
Active substance Dosage entrectinib 100 mg -
It is used to treat solid tumors (cancer) in adults, adolescents, and children older than 1 month of age who have an NTRK gene rearrangement. It is also used in adults with a type of non-small cell lung cancer that has a ROS1 gene rearrangement.
Dosage form: capsules, hard
Active substance Dosage entrectinib 200 mg -
It is used to treat influenza in adults, adolescents, children, and infants. It may also be prescribed to prevent influenza in people who have been in contact with someone infected or in exceptional situations such as a pandemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir phosphate 30 mg -
It is used to treat influenza in adults, adolescents, children, and infants. It may also be prescribed to prevent influenza in specific cases, such as after contact with an infected person, or in exceptional situations such as a pandemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir phosphate 45 mg -
It is used to treat influenza in adults, adolescents, children, and infants. It may also be prescribed to prevent influenza in specific cases (such as after being in contact with an infected person) or in exceptional situations such as a pandemic.
Dosage form: powder for preparation of oral suspension
Active substance Dosage oseltamivir phosphate 0,5122 g -
It is used to treat influenza in adults, adolescents, children, and infants. It may also be prescribed to prevent influenza in people who have been in contact with someone infected or in exceptional situations such as a pandemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir phosphate 75 mg -
It is used in adults to treat several types of cancer, including urothelial carcinoma (bladder), lung cancer (both small cell and non-small cell), triple-negative breast cancer, and liver cancer (hepatocellular).
Dosage form: solution for infusion, concentrate
Active substance Dosage atezolizumab 1200 mg -
It is used in adults to treat several types of cancer, including urothelial carcinoma (bladder), lung cancer (both small cell and non-small cell), triple-negative breast cancer, and liver cancer (hepatocellular).
Dosage form: solution for injection
Active substance Dosage atezolizumab 1875 mg -
It is used in adults to treat several types of cancer, including urothelial carcinoma (bladder), lung cancer (both small cell and non-small cell), triple-negative breast cancer, and liver cancer (hepatocellular).
Dosage form: solution for infusion, concentrate
Active substance Dosage atezolizumab 840 mg -
It is used to treat certain eye disorders in adults that affect central vision, such as neovascular age-related macular degeneration, diabetic macular edema, and macular swelling caused by retinal vein occlusion.
Dosage form: solution for injection
Active substance Dosage faricimab 28,8 mg -
It is used to treat eye disorders in adults that affect central vision, such as neovascular age-related macular degeneration (nAMD), vision impairment due to diabetic macular edema (DME), and vision impairment due to retinal vein occlusion (retinal branch vein occlusion or central retinal vein occlusion).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage faricimab 21 mg -
It is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery, provided they have a BRAF gene mutation.
Dosage form: tablets, film-coated
Active substance Dosage vemurafenib 240 mg